1,214 top medical experts on Serous Cystadenocarcinoma across 47 countries and 42 U.S. states, including 1,167 MDs (Physicians). This is based on an objective analysis of their Scientific Publications, Clinical Trials, Medicare, and NIH Grants.

  1. Serous Cystadenocarcinoma: A malignant cystic or semicystic neoplasm. It often occurs in the ovary and usually bilaterally. The external surface is usually covered with papillary excrescences. Microscopically, the papillary patterns are predominantly epithelial overgrowths with differentiated and undifferentiated papillary serous cystadenocarcinoma cells. Psammoma bodies may be present. The tumor generally adheres to surrounding structures and produces ascites. (From Hughes, Obstetric-Gynecologic Terminology, 1972, p185)
  2. Clinical guidelines are the recommended starting point to understand initial steps and current protocols in any disease or procedure:
  3. Broader Categories (#Experts): Cystadenocarcinoma (752).
  4. Clinical Trials ClinicalTrials.gov : at least 170 including 36 Active, 56 Completed, 46 Recruiting


  

        

                    


    Computing Expert Listing ...

);